VMP1 deficiency in mice recapitulates key features of non-alcoholic steatohepatitis, while VMP1 overexpression mitigates steatosis in non-alcoholic steatohepatitis, underscoring its essential role in the pathogenesis of non-alcoholic fatty liver disease. This evidence concerns the gene VMP1 and metabolic dysfunction-associated steatotic liver disease.